Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

por Horrigan, Stephen K
Publicado 2017

Replication Study: Melanoma genome sequencing reveals frequent PREX2 mutations

por Horrigan, Stephen K, Courville, Pascal, Sampey, Darryl, Zhou, Faren, Cai, Steve
Publicado 2017

Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo

por Savvidou, Ioanna, Khong, Tiffany, Whish, Sophie, Carmichael, Irena, Sepehrizadeh, Tara, Mithraprabhu, Sridurga, Horrigan, Stephen K., de Veer, Michael, Spencer, Andrew
Publicado 2022

Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction

por Thisted, Thomas, Biesova, Zuzana, Walmacq, Celine, Stone, Everett, Rodnick-Smith, Max, Ahmed, Shaheda S., Horrigan, Stephen K., Van Engelen, Bo, Reed, Charles, Kalnik, Matthew W.
Publicado 2019

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

por Braggio, Danielle Almeida, Costas C. de Faria, Fernanda, Koller, David, Jin, Feng, Zewdu, Abeba, Lopez, Gonzalo, Batte, Kara, Casadei, Lucia, Welliver, Meng, Horrigan, Stephen K., Han, Ruolan, Larson, Jeffrey L., Strohecker, Anne M., Pollock, Raphael E.
Publicado 2022